1.
|
JB VermorkenE RemenarC van
HerpenCisplatin, fluorouracil, and docetaxel in unresectable head
and neck cancerNew Eng J
Med35716951704200710.1056/NEJMoa07102817960012
|
2.
|
MR PosnerDM HershockCR BlajmanCisplatin
and fluorouracil alone or with docetaxel in head and neck cancerN
Engl J Med35717051715200710.1056/NEJMoa07095617960013
|
3.
|
JH LorchMR PosnerKJ GoloubevaLong-term
results from TAX324: a phase III trial of sequential therapy
comparing TPF to PF in locally advanced (LA) squamous cell cancer
of the head and neck (HNC)J Clin OncolSuppl2815s2010
|
4.
|
M BaghiM HambekA MayAdjuvant docetaxel,
cisplatin and 5-fluorouracil (TPF) in locally advanced squamous
cell carcinoma of the head and neckAnticancer
Res26559563200616739320
|
5.
|
M BaghiM HambekJ WagenblastA phase II
trial of docetaxel, cisplatin and 5-fluorouracil in patients with
recurrent squamous cell carcinoma of the head and neck
(SCCHN)Anticancer Res26585590200616739325
|
6.
|
T ShirasakiS MaruyaA NambaTreatment
results of chemotherapy with S-1 for head and neck cancerGan To
Kagaku Ryoho362372402009(In Japanese)
|
7.
|
JB VermorkenR MesiaF RiveraPlatinum-based
chemotherapy plus cetuximab in head and neck cancerNew Eng J
Med35911161127200810.1056/NEJMoa080265618784101
|
8.
|
MW SaifKN SyrigosNA KatirtzoglouS-1: a
promising new oral fluoropyrimidine derivativeExpert Opin Investig
Drugs18335348200910.1517/1354378090272941219243284
|
9.
|
J HuangY CaoL WuS-1-based therapy versus
5-FU-based therapy in advanced gastric cancer: a meta-analysisMed
Oncol2810041011201010.1007/s12032-010-9594-020552300
|
10.
|
N BokuS YamamotoH FukudaFluorouracil
versus combination of irinotecan plus cisplatin versus S-1 in
metastatic gastric cancer: a randomised phase 3 studyLancet
Oncol1010631069200910.1016/S1470-2045(09)70259-119818685
|
11.
|
W KoizumiH NaraharaT HaraS-1 plus
cisplatin versus S-1 alone for first-line treatment of advanced
gastric cancer (SPIRITS trial): a phase III trialLancet
Oncol9215221200810.1016/S1470-2045(08)70035-418282805
|
12.
|
M TaharaK ArakiS OkanoPhase I trial of
combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in
patients with locally advanced or recurrent/metastatic head and
neck cancerAnn Oncol22175180201010.1093/annonc/mdq29820530200
|
13.
|
K NakamuraM TaharaN KiyotaPhase II trial
of concurrent chemoradiotherapy with S-1 plus cisplatin in patients
with unresectable locally advanced squamous cell carcinoma of the
head and neck: Japan Clinical Oncology Group Study (JCOG0706)Jpn J
Clin Oncol39460463200910.1093/jjco/hyp040
|
14.
|
M FujiiK TomitaW NishijimaPhase I/II study
of S-1 plus cisplatin combination chemotherapy in patients with
advanced/recurrent head and neck cancerJpn J Clin
Oncol40214221201010.1093/jjco/hyp153
|
15.
|
YJ ChoiJS ChungHJ ShinInduction
chemotherapy with S-1 plus cisplatin in patients with locally
advanced squamous cell carcinoma of the head and neckJ Laryngol
Otol122848853200818047761
|
16.
|
DH YoonSB KimS-1 plus cisplatin: another
option in the treatment of advanced head and neck cancer?Expert Rev
Anticancer Ther10659662201010.1586/era.10.4520469998
|
17.
|
T ShirasakaDevelopment history and concept
of an oral anticancer agent S-1 (TS-1): its clinical usefulness and
future vistasJpn J Clin
Oncol39215200910.1093/jjco/hyn12719052037
|
18.
|
Y InuyamaA KidaM TsukudaS-1 Cooperative
Study Group (Head and Neck Cancer Working Group): Late phase II
study of S-1 in patients with advanced head and neck cancerGan To
Kagaku Ryoho28138113902001(In Japanese)
|
19.
|
J FerlayHR ShinF BrayGLOBOCAN2008Cancer
Incidence and Mortality Worldwide: IARC CancerBase No 10
[Internet]Lyon, FranceInternational Agency for Research on
Cancer2010Available from: http://globocan.iarc.fr
|
20.
|
JP PignonA le MaîtreE
MaillardMeta-analysis of chemotherapy in head and neck cancer
(MACH-NC): an update on 93 randomised trials and 17,346
patientsRadiother
Oncol92414200910.1016/j.radonc.2009.04.01419446902
|
21.
|
DJ AdelsteinY LiGL AdamsAn intergroup
phase III comparison of standard radiation therapy and two
schedules of concurrent chemoradiotherapy in patients with
unresectable squamous cell head and neck cancerJ Clin
Oncol219298200310.1200/JCO.2003.01.00812506176
|
22.
|
A PaccagnellaMG GhiL LoreggianConcomitant
chemoradiotherapy versus induction docetaxel, cisplatin and 5
fluorouracil (TPF) followed by concomitant chemoradiotherapy in
locally advanced head and neck cancer: a phase II randomized
studyAnn Oncol2115151522201010.1093/annonc/mdp573
|
23.
|
RI HaddadRB TishlerC NorrisPhase I study
of C-TPF in patients with locally advanced squamous cell carcinoma
of the head and neckJ Clin
Oncol2744484453200910.1200/JCO.2009.22.133319704061
|
24.
|
E Van CutsemVM MoiseyenkoS TjulandinV325
Study GroupPhase III study of docetaxel and cisplatin plus
fluorouracil compared with cisplatin and fluorouracil as first-line
therapy for advanced gastric cancer: a report of the V325 Study
GroupJ Clin Oncol2449914997200617075117
|
25.
|
Y SatoT TakayamaT SagawaPhase II study of
S-1, docetaxel and cisplatin combination chemotherapy in patients
with unresectable metastatic gastric cancerCancer Chemother
Pharmacol66721728201010.1007/s00280-009-1215-220041328
|
26.
|
N NakayamaW KoizumiT SasakiA multicenter,
phase I dose-escalating study of docetaxel, cisplatin and S-1 for
advanced gastric cancer
(KDOG0601)Oncology7517200810.1159/00015161318719348
|
27.
|
S FushidaT FujimuraK OyamaFeasibility and
efficacy of preoperative chemotherapy with docetaxel, cisplatin and
S-1 in gastric cancer patients with para-aortic lymph node
metastasesAnticancer
Drugs20752756200910.1097/CAD.0b013e32832ec02b19543076
|
28.
|
S HironakaK YamazakiK TakuPhase I study of
docetaxel, cisplatin and S-1 in patients with advanced gastric
cancerJpn J Clin Oncol4010141020201010.1093/jjco/hyq10420603245
|
29.
|
KJ ScanlonEM NewmanY LuBiochemical basis
for cisplatin and 5-fluorouracil synergism in human ovarian
carcinoma cellsProc Natl Acad Sci
USA8389238925198610.1073/pnas.83.23.89233466165
|
30.
|
G PratesiL GianniC ManzottiSequence
dependence of the antitumor and toxic effects of 5-fluorouracil and
cis-diamminedichloroplatinum combination on primary colon rumors in
miceCancer Chemother Pharmacol2123724019883359558
|
31.
|
M KurokiS NakanoK MitsugiIn vivo
comparative therapeutic study of optimal administration of
5-fluorouracil and cisplatin using a newly established HST-1 human
squamous-carcinoma cell lineCancer Chemother
Pharmacol29273276199210.1007/BF006859441537072
|
32.
|
MG FuryJP ShahInduction chemotherapy in
the management of head and neck cancerJ Surg
Oncol101292298201010.1002/jso.2143820187068
|
33.
|
W KreisD PetrylakD SavareseD BudmanColitis
and docetaxel-based
chemotherapyLancet3552164201010.1016/S0140-6736(05)72789-610902651
|